Penciclovir Recruiting Phase 1 Trials for Renal Cancers / Tumors / Colorectal Cancers / Triple Negative Breast Cancer (TNBC) / Other Solid Cancers / Bladder Cancers / Melanoma / Lung Cancer Non-Small Cell Cancer (NSCLC) / Head and Neck Carcinoma Treatment

RecruitingTreatment1 IdentifierTitleDrugs
NCT03289962A Study of RO7198457 (Personalized Cancer Vaccine [PCV]) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors